ORCHPHARMANSEOrchid Pharma Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 9 Jun, 2025 · 18:46 IST

Orchid Pharma Limited has informed the Exchange that Record date for the purpose of Meeting is 19-Jun-2025.

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

ORCHPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹728.00
prior close
₹728.35
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-0.5% vs market
Pharmaceuticals peers, median of 150sector+0.3%+0.0% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.4
15m
-0.9
30m
-0.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3+0.7-0.5+0.3+0.0
Next day
-1.4+1.2-2.6+1.0-2.3
2d
-0.7-0.3-0.4+0.7-1.4
3d
-1.7-0.7-1.0+0.1-1.8
4d
-3.2-0.4-2.8+0.0-3.2
5d
-3.6-1.4-2.2-1.0-2.6
1w
-6.5-3.4-3.0-3.4-3.1
15d
+1.6+0.9+0.7-0.2+1.8
1m
-0.8+1.5-2.2-0.4-0.3
2m
+6.7-3.6+10.4-3.4+10.1
3m
-2.1-0.8-1.3-2.7+0.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Orchid Pharma has fixed June 19, 2025 as the record date to determine which equity shareholders are eligible to vote in the upcoming NCLT-convened meeting. The meeting is scheduled for June 26, 2025, where shareholders will vote on the proposed Scheme of Amalgamation of Dhanuka Laboratories Limited (Amalgamating Company) into Orchid Pharma Limited (Amalgamated Company). The scheme was earlier notified on May 25, 2025 along with the meeting notice. The record date has been set under SEBI Listing Regulations (Regulation 42).

Likely market impact

This is a procedural step toward completing the merger of Dhanuka Laboratories into Orchid Pharma. Shareholders holding shares as of June 19, 2025 will have voting rights on the deal. Approval at the June 26 meeting would move the amalgamation closer to completion, which could be a significant event for both sets of shareholders.